- Home
- UONEK vs IGC Comparison
UONEK vs IGC Comparison
Compare UONEK & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UONEK | IGC |
|---|---|---|
| Founded | 1980 | 2005 |
| Country | United States | United States |
| Employees | 1396 | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 25.0M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | UONEK | IGC |
|---|---|---|
| Price | $5.40 | $0.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 2.8K | ★ 231.2K |
| Earning Date | 05-12-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.09 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,271,000.00 |
| Revenue This Year | N/A | $3.54 |
| Revenue Next Year | N/A | $15.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.44 | $0.24 |
| 52 Week High | $9.38 | $0.50 |
Technical Indicators
Market Signals| Indicator | UONEK | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 48.00 |
| Support Level | $0.68 | $0.25 |
| Resistance Level | $8.95 | $0.31 |
| Average True Range (ATR) | 0.56 | 0.02 |
| MACD | -0.15 | -0.00 |
| Stochastic Oscillator | 19.48 | 41.96 |
Price Performance
Historical ComparisonAbout UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.